Concepedia
Statistics
Publications
24
Citations
1.4K
H-Index
18
Active since
1961
Affiliations
Novartis (Switzerland)(Current)
Novartis (United States)
Université Libre de Bruxelles
Novartis Institutes for BioMedical Research
Université de Strasbourg
Laurence Colin is an author at Novartis (Switzerland) specializing in life sciences, molecular biology, and medicine.
Publications per year
1961–2020
Factors influencing the retention of cemented gold castings
Edward G. Kaufman, David H. Coelho, Laurence Colin · Journal of Prosthetic Dentistry · 1961 · 232 citations
Engineering, Materials Engineering, Materials Science +12
Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients
Sophie Bouchat, Jean‐Stéphane Gatot, Kabamba Kabeya et al. · AIDS · 2012 · 147 citations · Full text
Life Sciences, Immunology, Molecular Biology +15
Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin
Geremia B. Bolli, Francesco Dotta, Laurence Colin et al. · Diabetes Obesity and Metabolism · 2009 · 104 citations
Medicine, Pharmacology, Pharmacotherapy +17
A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, for Control of Graves Hyperthyroidism—A Proof-of-Concept Trial
George J. Kahaly, Marius N. Stan, Lara Frommer et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 96 citations
Life Sciences, Endocrinology, Immunology +17
First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody
Pascal Espié, Yanling He, Phillip J. Koo et al. · American Journal of Transplantation · 2019 · 91 citations
Medicine, Pharmacokinetics, Pharmacology +17
1–5 of 24